Investigational Site Number :8040007

Kyiv 04050

0 studies enrolling now · 6 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis Without Nasal Polyps, Chronic Sinusitis, Relapsing Multiple Sclerosis, Respiratory Disorder, Sinus Disorder, Sinusitis

Studies at this site

• Dupilumab in CRSsNP — Completed
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed
• A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma — Completed
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants — Completed